TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation

Kidney International

Volumn 81, Issue 11, 2012, Pages 1098-1107

  Izquierdo, María Concepción ^a   Sanz, Ana B ^b   Mezzano, Sergio ^c   Blanco, Julia ^d   Carrasco, Susana ^a   Sanchez Nĩo, María Dolores ^b   Benito Martín, Alberto ^a   Ruiz Ortega, Marta ^a   Egido, Jess ^a   Ortiz, Alberto ^a,c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^c UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

acute kidney injury; chemokine; glomerulonephritis; inflammation

Indexed keywords

CXCL16 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PARTHENOLIDE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY TUBULE CELL; LYMPHOCYTIC INFILTRATION; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; T LYMPHOCYTE ACTIVATION; TRANSCRIPTOMICS; UPREGULATION;

EID: 84861192529     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.475     Document Type: Article

References (57)

1. Chung AC, Lan HY. Chemokines in renal injury. J Am Soc Nephrol 2011; 22: 802-809.
2. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104: 487-501. (Pubitemid 32201945)
3. Sanz AB, Justo P, Sanchez-Nino MD et al. The cytokine TWEAK modulates renal tubulointerstitial inflammation. J Am Soc Nephrol 2008; 19: 695-703.
4. Justo P, Sanz AB, Sanchez-Nino MD et al. Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int 2006; 70: 1750-1758. (Pubitemid 44684806)
5. Campbell S, Burkly LC, Gao HX et al. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells. J Immunol 2006; 176: 1889-1898. (Pubitemid 43134334)
6. Carragher D, Johal R, Button A et al. A stroma-derived defect in NFkappaB2-/- mice causes impaired lymph node development and lymphocyte recruitment. J Immunol 2004; 173: 2271-2279. (Pubitemid 39063082)
7. Zhao Z, Burkly LC, Campbell S et al. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versushost model of systemic lupus erythematosus. J Immunol 2007; 179: 7949-7958.
8. Campbell S, Michaelson J, Burkly L et al. The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity. Front Biosci 2004; 9: 2273-2284.
9. Harada N, Nakayama M, Nakano H et al. Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells. Biochem Biophys Res Commun 2002; 299: 488-493. (Pubitemid 35365656)
10. Chicheportiche Y, Chicheportiche R, Sizing I et al. Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies. Arthritis Res 2002; 4: 126-133. (Pubitemid 34257346)
11. Tran NL, McDonough WS, Savitch BA et al. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression. J Biol Chem 2005; 280: 3483-3492. (Pubitemid 40223813)
12. Sanz AB, Sanchez-Nino MD, Izquierdo MC et al. TWEAK activates the noncanonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21. PLoS ONE 2010; 5: e8955.
13. Xu H, Okamoto A, Ichikawa J et al. TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF. Biochem Biophys Res Commun 2004; 318: 422-427. (Pubitemid 38553796)
14. Jin L, Nakao A, Nakayama M et al. Induction of RANTES by TWEAK/Fn14 interaction in human keratinocytes. J Invest Dermatol 2004; 122: 1175-1179. (Pubitemid 38651092)
15. Ludwig A, Weber C. Transmembrane chemokines: versatile 'special agents' in vascular inflammation. Thromb Haemost 2007; 97: 694-703. (Pubitemid 46779956)
16. Koziolek MJ, Vasko R, Bramlage C et al. The CX(3)C-chemokine fractalkine in kidney diseases. Mini Rev Med Chem 2009; 9: 1215-1228.
17. Shimaoka T, Kume N, Minami M et al. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem 2000; 275: 40663-40666. (Pubitemid 32054881)
18. Matloubian M, David A, Engel S et al. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 2000; 1: 298-304.
19. Bazan JF, Bacon KB, Hardiman G et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997; 385: 640-644.
20. Pan Y, Lloyd C, Zhou H et al. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 1997; 387: 611-617. (Pubitemid 27248766)
21. Imai T, Hieshima K, Haskell C et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997; 91: 521-530. (Pubitemid 27508241)
22. Shimaoka T, Nakayama T, Fukumoto N et al. Cell surface-anchored SRPSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J Leukoc Biol 2004; 75: 267-274. (Pubitemid 38174584)
23. Schramme A, Abdel-Bakky MS, Gutwein P et al. Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney. Kidney Int 2008; 74: 328-338. (Pubitemid 352001245)
24. Schramme A, Abdel-Bakky MS, Kampfer-Kolb N et al. The role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cells. Biochem Biophys Res Commun 2008; 370: 311-316.
25. Gutwein P, Abdel-Bakky MS, Schramme A et al. CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein. Am J Pathol 2009; 174: 2061-2072.
26. Garcia GE, Truong LD, Li P et al. Inhibition of CXCL16 attenuates inflammatory and progressive phases of anti-glomerular basement membrane antibody-associated glomerulonephritis. Am J Pathol 2007; 170: 1485-1496. (Pubitemid 47339295)
27. Wu T, Xie C, Wang HW et al. Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J Immunol 2007; 179: 7166-7175.
28. Wu T, Xie C, Bhaskarabhatla M et al. Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance. Arthritis Rheum 2007; 56: 949-959. (Pubitemid 46399442)
29. Ortega A, Ramila D, Ardura JA et al. Role of parathyroid hormone-related protein in tubulointerstitial apoptosis and fibrosis after folic acid-induced nephrotoxicity. J Am Soc Nephrol 2006; 17: 1594-1603. (Pubitemid 43794662)
30. Fang TC, Alison MR, Cook HT et al. Proliferation of bone marrow-derived cells contributes to regeneration after folic acid-induced acute tubular injury. J Am Soc Nephrol 2005; 16: 1723-1732. (Pubitemid 41716478)
31. Doi K, Okamoto K, Negishi K et al. Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. Am J Pathol 2006; 168: 1413-1424.
32. Welsh-Bacic D, Lindenmeyer M, Cohen CD et al. Expression of the chemokine receptor CCR6 in human renal inflammation. Nephrol Dial Transplant 2011; 26: 1211-1220.
33. Koziolek MJ, Muller GA, Zapf A et al. Role of CX3C-chemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure. Nephrol Dial Transplant 2010; 25: 684-698.
34. Gao HX, Campbell SR, Burkly LC et al. TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells. Cytokine 2009; 46: 24-35.
35. Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 1997; 51: 2-15. (Pubitemid 27064516)
36. van KC, Daha MR, van Es LA. Tubular epithelial cells: a critical cell type in the regulation of renal inflammatory processes. Exp Nephrol 1999; 7: 429-437. (Pubitemid 29517353)
37. Sanz AB, Sanchez-Nino MD, Izquierdo MC et al. Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia. J Cell Mol Med 2009; 13: 3329-3342.
38. Hattermann K, Ludwig A, Gieselmann V et al. The chemokine CXCL16 induces migration and invasion of glial precursor cells via its receptor CXCR6. Mol Cell Neurosci 2008; 39: 133-141.
39. Dahl CP, Husberg C, Gullestad L et al. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling. Circ Heart Fail 2009; 2: 624-632.
40. Huang Y, Zhu XY, Du MR et al. Chemokine CXCL16, a scavenger receptor, induces proliferation and invasion of first-trimester human trophoblast cells in an autocrine manner. Hum Reprod 2006; 21: 1083-1091.
41. Zhuge X, Murayama T, Arai H et al. CXCL16 is a novel angiogenic factor for human umbilical vein endothelial cells. Biochem Biophys Res Commun 2005; 331: 1295-1300. (Pubitemid 40692497)
42. Chandrasekar B, Bysani S, Mummidi S. CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factorkappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. J Biol Chem 2004; 279: 3188-3196. (Pubitemid 38140551)
43. Deng L, Chen N, Li Y et al. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer. Biochim Biophys Acta 2010; 1806: 42-49.
44. Hofnagel O, Luechtenborg B, Plenz G et al. Expression of the novel scavenger receptor SR-PSOX in cultured aortic smooth muscle cells and umbilical endothelial cells. Arterioscler Thromb Vasc Biol 2002; 22: 710-711. (Pubitemid 34408758)
45. Shashkin P, Simpson D, Mishin V et al. Expression of CXCL16 in human T cells. Arterioscler Thromb Vasc Biol 2003; 23: 148-149. (Pubitemid 36091640)
46. Wilbanks A, Zondlo SC, Murphy K et al. Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines. J Immunol 2001; 166: 5145-5154. (Pubitemid 32280729)
47. Singbartl K, Ley K. Leukocyte recruitment and acute renal failure. J Mol Med 2004; 82: 91-101. (Pubitemid 38299708)
48. Olson TS, Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 2002; 283: R7-28.
49. Schwartz N, Rubinstein T, Burkly LC et al. Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Arthritis Res Ther 2009; 11: R143.
50. Sanz AB, Sanchez-Nino MD, Ramos AM et al. NF-kappaB in renal inflammation. J Am Soc Nephrol 2010; 21: 1254-1262.
51. Strutz F, Zeisberg M, Ziyadeh FN et al. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 2002; 61: 1714-1728. (Pubitemid 34437925)
52. Strutz F, Okada H, Lo CW et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995; 130: 393-405.
53. Hotta K, Sho M, Yamato I et al. Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury. Kidney Int 2011; 79: 179-188.
54. Winkles JA. The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov 2008; 7: 411-425. (Pubitemid 351619113)
55. Ortiz A, Lorz C, Gonzalez-Cuadrado S et al. Cytokines and Fas regulate apoptosis in murine renal interstitial fibroblasts. J Am Soc Nephrol 1997; 8: 1845-1854. (Pubitemid 28185442)
56. Ortiz A, Lorz C, Catalan MP et al. Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. Kidney Int 2000; 57: 969-981. (Pubitemid 30434787)
57. Lorz C, Ortiz A, Justo P et al. Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J Am Soc Nephrol 2000; 11: 1266-1277. (Pubitemid 30416223)